Patents-Review.com
🔗 Permalink
Assignee profile:

Boehringer Ingelheim (Canada) Ltd.

City:

Laval

Country:

Canada

Published Applications:

22

Last publication date:

2008-10-21

Patent Grants:

20

Last grant date:

2008-10-21

Top Inventors for applications by Boehringer Ingelheim (Canada) Ltd.

These are the the leading inventors for applications assigned to Boehringer Ingelheim (Canada) Ltd.:

Recent patent applications by Boehringer Ingelheim (Canada) Ltd.

Boehringer Ingelheim (Canada) Ltd. based in Laval, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2008-10-21 ✅ Patent 7,439,258 granted on 2008-10-21
US10851710
-

Viral polymerase inhibitors

 #2 | 2008-03-18 ✅ Patent 7,344,723 granted on 2008-03-18
US10789355
-

Self-replicating RNA molecule from hepatitis C virus

 #3 | 2007-11-13 ✅ Patent 7,294,457 granted on 2007-11-13
US10211455
-

Direct binding assay for identifying inhibitors of HCV polymerase

 #4 | 2007-10-02 ✅ Patent 7,276,373 granted on 2007-10-02
US10328206
-

Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease

 #5 | 2007-09-25 ✅ Patent 7,273,861 granted on 2007-09-25
US10662606
-

Non-nucleoside reverse transcriptase inhibitors

 #6 | 2007-09-04 ✅ Patent 7,264,811 granted on 2007-09-04
US10650585
-

Purified active HCV NS2/3 protease

 #7 | 2007-07-26
US20070172936A1
Chemistry; metallurgy

Purified active HCV NS2/3 protease

 #8 | 2007-01-23 ✅ Patent 7,167,801 granted on 2007-01-23
US10193460
-

Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates

 #9 | 2007-01-02 ✅ Patent 7,157,486 granted on 2007-01-02
US10198680
-

Viral polymerase inhibitors

 #10 | 2006-11-28 ✅ Patent 7,141,574 granted on 2006-11-28
US10198384
-

Viral polymerase inhibitors

 #11 | 2006-11-02 ✅ Patent 7,919,312 granted on 2011-04-05
US20060246424A1
Chemistry; metallurgy

Self-replicating RNA molecule from hepatitis C virus

 #12 | 2006-10-19 ✅ Patent 7,528,167 granted on 2009-05-05
US20060235010A1
Chemistry; metallurgy

Inhibitors of papilloma virus

 #13 | 2006-10-10 ✅ Patent 7,119,072 granted on 2006-10-10
US10353894
-

Macrocyclic peptides active against the hepatitis C virus

 #14 | 2006-09-12 ✅ Patent 7,105,510 granted on 2006-09-12
US10662856
-

Non-nucleoside reverse transcriptase inhibitors

 #15 | 2006-07-20 ✅ Patent 7,576,079 granted on 2009-08-18
US20060160798A1
Chemistry; metallurgy

Viral polymerase inhibitors

 #16 | 2005-12-29
US20050287554A1
Chemistry; metallurgy

Regions of papilloma virus E1 helicase involved in E1 oligomerization

 #17 | 2005-10-27 ✅ Patent 7,323,567 granted on 2008-01-29
US20050239814A1
Chemistry; metallurgy

RSV polymerase inhibitors

 #18 | 2005-10-18 ✅ Patent 6,956,117 granted on 2005-10-18
US10309561
-

Self-replicating RNA molecule from hepatitis C virus

 #19 | 2005-10-13 ✅ Patent 7,838,207 granted on 2010-11-23
US20050227226A1
Chemistry; metallurgy

Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease

 #20 | 2005-07-12 ✅ Patent 6,916,622 granted on 2005-07-12
US10339268
-

Regions of papilloma virus E1 helicase involved in E1 oligomerization

 #21 | 2005-02-08 ✅ Patent 6,852,501 granted on 2005-02-08
US10041522
-

Methods for determining ATPase activity and uses thereof

 #22 | 2005-01-13 ✅ Patent 7,119,099 granted on 2006-10-10
US20050009855A1
Chemistry; metallurgy

Inhibitors of papilloma virus
AssigneeID:

282798 ⎘